
Saturday, March 16, 2024 5:40:15 PM
2007 (ORS Annual Meeting Feb 11-14)
THERMAL CONDUCTIVITY OF FEMORAL BALL STRONGLY INFLUENCED UHMWPE WEAR IN A HIP SIMULATOR STUDY
Ten 28 mm ID isostatically moulded UHMWPE liners were investigated: GUR 1050 resin, gamma-sterilized with 25ñ40 kGy in argon (ArComô, Biomet Inc, Warsaw, IN). The liners were coupled with zirconia (Y-ZrO 2 : ProzyrÆ), cobalt-chrome (Biomet, Inc), silicon nitride (Si3 N 4 : Amedica-Inc, UT) and alumina femoral balls (Al2 O 3 : Biolox-forteÆ) (Figure 1).
Acknowledgements The authors thank Amedica, Utah, US and Biomet Inc, US for their support
2015 - Signed JDA
In 2015 Sintx signed a JDA with a company to develop Si3N4 based devices and since that time, their products have been used with Biomet IP and tested at a facility Biomet was already testing. The JDA was signed before Dr Pezzotti joined Sintx Scientific Board Sept 2015 who happened to have done years worth of studies for Biomet. I have always thought this R&D agreement was connected to Zimmer. If it was indeed signed with Biomet, it was signed in May just a month before the merger between Zimmer and Biomet officially closed June 24th. The timing of which i always felt was suspect and purposeful.
To kick off things there is the JDA that was not revealed until Sept 2017 on the delayed 10K filing.
On May 13, 2015, the Company entered into a joint agreement for research and development of silicon nitride based devices. This agreement is effective for a period of five years from the date of commencement. The Company incurred payments of $270,000 and $270,000 related to this agreement for the years ended December 31, 2016 and 2015, respectively.
Next, on the 2015 10k, its reveled that they have initiated testing of their femoral head with a strategic partner that is to run into 2016.
Together with a strategic partner, we have initiated biomechanical testing of our solid silicon nitride femoral heads. This testing is expected to continue through 2016. If the tests indicate that silicon nitride femoral heads are superior in terms of wear performance, taper corrosion, strength and in vitro hydrothermal stability, we eventually intend to commercialize this product in cooperation with a strategic partner.
During that same period of time Sintx just happened to fund (partially fund?) a study testing its femoral head at the University of Nebraska the same location that Biomet uses for some of its testing. By itself could just be a coincidence but coupled with other connections it looks like Biomet is the reason this testing is going on at this location.
Amedica - Comparative Testing of Ceramic Femoral Heads for Total Hip Arthroplasty, 2015-2016
Separately, it seems, another study was underway in Japan testing Sintx femoral Head and Biomet's E1 liner, for which Zimmer Biomet supplied for testing. 2020, that testing was officially published.
2017
comparative hip simulator study examining the wear behavior of an advanced highly cross-linked and vitamin E stabilized polyethylene (E1® Zimmer-Biomet, Warsaw, IN, USA)
Amedica and Zimmer-Biomet (Tokyo Office) provided the femoral heads and acetabular liners; however, neither company actively sponsored the research.
Published study on this testing:
Wear Simulation of Ceramic-on-Crosslinked Polyethylene Hip Prostheses: A New Non-Oxide Silicon Nitride versus the Gold Standard Composite Oxide Ceramic Femoral Heads
Last we have publication of another component which involved Sintx using Biomet's G7 shell to test its Si3n4 coating tech. The only thing missing from a hip implant is a femoral stem. This could be the final component being worked on with Sintx collaboration with 3DCeram Sinto to perfect 3D printing of a Si3n4 which would allow Sintx to print a porous femoral stem that has a much lower modulus of elasticity.
2019
3D-additive deposition of an antibacterial and osteogenic silicon nitride coating on orthopaedic titanium substrate
Zimmer Biomet G7 OsseoTi Limited Actabular Shell (4 Hole) - Si3N4 Coated
Quote Sources:
1. http://c.eqcdn.com/_5c7526ae538a6086a4025ef13f5136d2/amedica/db/265/660/pdf/0278.pdf
2. https://www.sec.gov/Archives/edgar/data/1269026/000149315217010752/form10-k.htm pg F-24
3. https://www.sec.gov/Archives/edgar/data/1269026/000149315216008221/form10-k.htm pg 12
4. https://web.archive.org/web/20230519175028/http://www.unmc.edu/orthosurgery/research/grants.html
5. https://ir.sintx.com/news-events/press-releases/detail/95/amedica-announces-results-of-independent-femoral-head-wear
6. https://www.mdpi.com/1996-1944/13/13/2917
7. https://www.sciencedirect.com/science/article/abs/pii/S1751616119309099
Extra information on the status of a Si3n4 based hip implant:
Silicon nitride, silicon carbide and diamond-like carbon as non-oxide ceramics are considered to be the new generation of materials used in hip prosthetics, particularly in the manufacture of acetabular cups, due to their excellent biocompatibility, osteointegration, and tribological and mechanical properties, but all three materials need more study. However, silicon nitride is the nearest to commercialization, through businesses such as Amedica Corp. and SyntX Technologies
Im guessing the authors meant Sintx Technologies. Amedica being the companies former name before the name was sold to CTL.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10422432/
Could it be that there is a strategy to distract people away from looking at the basic data?
Is all this an exercise to create more and more forum verbiage to drown out any serious discussion of evidence?
Recent SINT News
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 02/14/2025 10:08:19 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 02/14/2025 09:42:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/23/2024 09:15:30 PM
- SINTX Technologies Secures Patent Allowance for Wide-Ranging Silicon Nitride Biomaterial Applications • GlobeNewswire Inc. • 12/17/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/13/2024 09:15:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/29/2024 06:15:19 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 11/26/2024 11:10:12 AM
- SINTX Technologies and NED Medical Partner to Advance Cutting-Edge Ceramic Microsphere Medical Devices for Cancer Treatment • GlobeNewswire Inc. • 11/21/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/19/2024 10:13:22 PM
- SINTX Technologies Appoints Gregg R. Honigblum as Chief Strategy Officer • GlobeNewswire Inc. • 11/19/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/18/2024 11:15:16 AM
- Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 11/15/2024 12:25:52 AM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/14/2024 09:15:08 PM
- SINTX Technologies Provides Positive Strategic Business Update for Q3 2024 • GlobeNewswire Inc. • 11/14/2024 11:00:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/12/2024 08:50:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/01/2024 08:30:16 PM
- SINTX Announces Key Executive Promotions: Ryan Bock, PhD, Named Chief Technology Officer and Ann Kutsch Promoted to President of SINTX TA&T • GlobeNewswire Inc. • 10/01/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/26/2024 08:30:31 PM
- Prodways and SINTX Announce Joint Webinar Stay Ahead of the Curve: “Innovations in Ceramic Manufacturing: The Role of 3D Printing” • GlobeNewswire Inc. • 09/20/2024 12:00:00 PM
- SINTX Announces Completion of $3.1 Million ATM Equity Public Offering • GlobeNewswire Inc. • 09/19/2024 12:00:00 PM
- Apple Loses EU Dispute; Google’s $2.7 Billion Fine Upheld; Oracle Shares Surge 9% • IH Market News • 09/10/2024 10:02:31 AM
- SINTX Receives Notice of Allowance for United States Patent Application for Silicon Nitride-Functionalized Zirconia-Toughened Alumina Ceramic Biomaterial • GlobeNewswire Inc. • 09/09/2024 12:00:00 PM
- Significant Cost Reductions, Extended Cash Runway, and Exploration of Strategic Partnerships • GlobeNewswire Inc. • 09/05/2024 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2024 08:32:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/06/2024 01:05:17 PM
COEPTIS Announces the Launch of COEP Venture Group to Invest in AI, RPA, and AI Agent Startups • COEP • Feb 13, 2025 9:10 AM
Unitronix Corp. to Report Over 300% Gains in Cryptocurrency Assets • UTRX • Feb 13, 2025 7:15 AM
Hivello Token ($HVLO) now Live • MATE • Feb 11, 2025 9:27 AM
Animoca Brands leads Hivello funding round ahead of Token Listing • MATEF • Feb 10, 2025 10:20 AM
51 Labs Expands Sports Nutrition Line with Five New Innovative Products, Company in final phase of name and ticker symbol change • CAFI • Feb 10, 2025 9:00 AM
UAV Corp. Expanding in the Global UAV Market, Projected to Exceed $58 Billion by 2027, with Increasing Government and Commercial Sector Adoption • UMAV • Feb 6, 2025 8:30 AM